Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Brain Disorders

3,4-dihydroxyphenylacetic acid has been researched along with Brain Disorders in 15 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
" All of these effects of ATR were observed at levels that were not toxic to the tissue, as LDH release into the medium (lactate dehydrogenase, an index of non-specific cytotoxicity) was not affected by ATR."1.34Dopaminergic toxicity of the herbicide atrazine in rat striatal slices. ( Carr, RL; Filipov, NM; Sistrunk, SC; Stewart, MA, 2007)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19903 (20.00)18.7374
1990's8 (53.33)18.2507
2000's4 (26.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winter, C1
Djodari-Irani, A1
Sohr, R1
Morgenstern, R1
Feldon, J1
Juckel, G1
Meyer, U1
Moroz, IA1
Peciña, S1
Schallert, T1
Stewart, J1
Filipov, NM1
Stewart, MA1
Carr, RL1
Sistrunk, SC1
Melamed, E1
Hefti, F1
Bird, ED1
Hantraye, P1
Guibert, B1
Biguet, NF1
Lavergne, A1
Leviel, V1
Obata, T1
Yamanaka, Y1
Kondoh, T1
Low, WC1
Hossain, MA1
Weiner, N1
Lan, J1
Jiang, DH1
Klivenyi, P1
St Clair, D1
Wermer, M1
Yen, HC1
Oberley, T1
Yang, L1
Flint Beal, M1
Xia, XG1
Schmidt, N1
Teismann, P1
Ferger, B1
Schulz, JB1
Gordon, K1
Statman, D1
Johnston, MV1
Robinson, TE2
Becker, JB1
Silverstein, FS1
Castañeda, E1
Whishaw, IQ1
Bradbury, AJ1
Costall, B1
Domeney, AM1
Testa, B1
Jenner, PG1
Marsden, CD1
Naylor, RJ1
Fibiger, HC1
LePiane, FG1
Jakubovic, A1
Phillips, AG1

Reviews

1 review available for 3,4-dihydroxyphenylacetic acid and Brain Disorders

ArticleYear
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice.
    Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:4-5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Disease

1997

Other Studies

14 other studies available for 3,4-dihydroxyphenylacetic acid and Brain Disorders

ArticleYear
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
    The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Brain Diseases; Chromatography, High Press

2009
Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Experimental neurology, 2004, Volume: 189, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Behav

2004
Dopaminergic toxicity of the herbicide atrazine in rat striatal slices.
    Toxicology, 2007, Mar-22, Volume: 232, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atrazine; Brain Diseases; Corpus Striatum; Dopamine; Dopami

2007
Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions.
    Neurology, 1982, Volume: 32, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Corpus Striatum; Dopamine; Female; Homovani

1982
TH mRNA over-expression in rats with chronic excitotoxic striatal lesions.
    Neuroreport, 1994, Dec-20, Volume: 5, Issue:18

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Caudate Nucleus; Chronic Disease; Co

1994
Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation by monoamine oxidase inhibitor in the rat.
    Neuroscience letters, 1995, Mar-16, Volume: 188, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Corpus Striatum; Dopamine; Free Radi

1995
Glutamate uptake blockade induces striatal dopamine release in 6-hydroxydopamine rats with intrastriatal grafts: evidence for host modulation of transplanted dopamine neurons.
    Experimental neurology, 1994, Volume: 127, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Brain Tissue Transplantation; Corpus

1994
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biopterins; Brain Diseases; Carbidopa; Corpus Striatum; Cyc

1993
Manganese superoxide dismutase overexpression attenuates MPTP toxicity.
    Neurobiology of disease, 1998, Volume: 5, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic

1998
Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
    Journal of neurochemistry, 2001, Volume: 79, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Benzazepines; Brain Diseases; Carbido

2001
Transient hypoxia alters striatal catecholamine metabolism in immature brain: an in vivo microdialysis study.
    Journal of neurochemistry, 1990, Volume: 54, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Brain Diseases; Corpus Striatum; Dialysis

1990
Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1990, Volume: 10, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dialysis; Dop

1990
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Neuroscience letters, 1985, Oct-24, Volume: 61, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic

1985
The role of dopamine in intracranial self-stimulation of the ventral tegmental area.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1987, Volume: 7, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Corpus Striatum; Dopamine; Electric Stimula

1987